middle.news

Merger challenge opens a new test for Genetic Signatures and Microba

5:29pm on Friday 13th of November, 2026 AEDT • Healthcare
Read Story

Merger challenge opens a new test for Genetic Signatures and Microba

5:29pm on Friday 13th of November, 2026 AEDT
Key Points
  • BCAL Diagnostics holds 18.46% of Genetic Signatures
  • Challenge targets deal protections and shareholder disclosure
  • Revised transaction would leave Microba shareholders with 60% of the combined group
  • Interim orders could affect the AGM resolution and scheme deed
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Microba Life Sciences (ASX:MAP)
OPEN ARTICLE